LABELING OF EHDP WITH RE-186 AND INTEREST OF THIS COMPLEX IN THE TREATMENT OF BONE METASTASES

被引:0
|
作者
MATHIEU, L
CHEVALIER, P
GALY, G
BERGER, M
机构
关键词
D O I
10.1016/0047-0740(80)90078-9
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
引用
收藏
页码:210 / 211
页数:2
相关论文
共 50 条
  • [1] PREPARATION OF RE-186 LABELED EHDP AND ITS POSSIBLE USE IN THE TREATMENT OF OSSEOUS NEOPLASMS
    MATHIEU, L
    CHEVALIER, P
    GALY, G
    BERGER, M
    INTERNATIONAL JOURNAL OF APPLIED RADIATION AND ISOTOPES, 1979, 30 (12): : 725 - 727
  • [2] PREPARATION OF CYCLOTRON Re-186 AND COMPARISON WITH REACTOR Re-186 AND GENERATOR Re-188 FOR THE LABELING OF BOMBESIN
    Ehrhardt, G. J.
    Moustapha, M. E.
    Smith, C. J.
    Szajek, L.
    Eckelmann, W. C.
    Jurisson, S. S.
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2005, 48 : S16 - S16
  • [3] RE-186 HYDROXYETHYLIDENE DIPHOSPHONATE FOR THE TREATMENT OF PAINFUL OSSEOUS METASTASES
    MAXON, HR
    THOMAS, SR
    HERTZBERG, VS
    SCHRODER, LE
    ENGLARO, EE
    SAMARATUNGA, R
    SCHER, HI
    MOULTON, JS
    DEUTSCH, EA
    DEUTSCH, KF
    SCHNEIDER, HJ
    WILLIAMS, CC
    EHRHARDT, GJ
    SEMINARS IN NUCLEAR MEDICINE, 1992, 22 (01) : 33 - 40
  • [4] PHARMACOKINETICS OF RE-186 AFTER ADMINISTRATION OF RHENIUM-186-HEDP TO PATIENTS WITH BONE METASTASES
    DEKLERK, JMH
    VANDIJK, A
    VANHETSCHIP, AD
    ZONNENBERG, BA
    VANRIJK, PP
    JOURNAL OF NUCLEAR MEDICINE, 1992, 33 (05) : 646 - 651
  • [5] STUDIES ON THE PREPARATION OF RE-186 DTPA COMPLEXES USING LOW SPECIFIC ACTIVITY RE-186 FOR ANTIBODY LABELING
    MAJALI, MA
    JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY-ARTICLES, 1993, 170 (02): : 471 - 477
  • [6] Palliation of skeletal metastases with rhenium (Re-186 HEDP)
    Schoeneich, G
    Palmedo, H
    Heimbach, D
    Winter, P
    Biersack, HJ
    Muller, SC
    AKTUELLE UROLOGIE, 1997, 28 (06) : 329 - 332
  • [7] Palliative analgesic effect of Re-186 HEDP in various cancer patients with bone metastases
    N. Ö. Küçük
    E. İbiş
    G. Aras
    S. Baltaci
    G. Özalp
    Y. Bedük
    N. Çanakci
    A. Soylu
    Annals of Nuclear Medicine, 2000, 14 : 239 - 245
  • [8] Remission of bone metastases after combined chemotherapy and radionuclide therapy with Re-186 HEDP
    Palmedo, H
    Grunwald, F
    Wagner, U
    Kohler, S
    Krebs, D
    Biersack, HJ
    CLINICAL NUCLEAR MEDICINE, 1998, 23 (08) : 501 - 504
  • [9] RE-186 HEDP - A POTENTIAL THERAPEUTIC BONE AGENT
    WEININGER, J
    KETRING, AR
    DEUTSCH, E
    MAXON, HR
    GOECKELER, WR
    JOURNAL OF NUCLEAR MEDICINE, 1983, 24 (05) : P125 - P125
  • [10] PHARMACOKINETICS OF RE-186 AFTER ADMINISTRATION OF RHENIUM-186-HEDP TO PATIENTS WITH BONE METASTASES AND MEANING OF THE BONE-SCAN INDEX
    DEKLERK, JMH
    VANDIJK, A
    SCHIP, ADV
    HAKMAN, ME
    ZONNENBERG, BA
    VANRIJK, PP
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1992, 19 (08): : 623 - 623